Drug Profile
Gensci 007 (biosimilar)
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator GeneScience Pharmaceuticals
- Class Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Undefined in China (Parenteral)
- 21 Jun 2012 Clinical trials in Undefined indication in China (Parenteral)